NOVEL COMPOUNDS

There are provided inter alia compounds of formula (I) wherein R1, R2a, R2b, R3, R4, L, X, R5 and R6 are as defined in the description for use in the treatment of inflammatory diseases.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HARDY GEORGE, MURRAY PETER JOHN, ONIONS STUART THOMAS, WILLIAMS JONATHAN GARETH, KING-UNDERWOOD JOHN
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	HARDY GEORGE MURRAY PETER JOHN ONIONS STUART THOMAS WILLIAMS JONATHAN GARETH KING-UNDERWOOD JOHN
description	There are provided inter alia compounds of formula (I) wherein R1, R2a, R2b, R3, R4, L, X, R5 and R6 are as defined in the description for use in the treatment of inflammatory diseases.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2016130256A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2016130256A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2016130256A13</originalsourceid><addsrcrecordid>eNrjZOD38w9z9VFw9vcN8A_1cwnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoZmhsYGRqZmjobGxKkCAGToHjo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL COMPOUNDS</title><source>esp@cenet</source><creator>HARDY GEORGE ; MURRAY PETER JOHN ; ONIONS STUART THOMAS ; WILLIAMS JONATHAN GARETH ; KING-UNDERWOOD JOHN</creator><creatorcontrib>HARDY GEORGE ; MURRAY PETER JOHN ; ONIONS STUART THOMAS ; WILLIAMS JONATHAN GARETH ; KING-UNDERWOOD JOHN</creatorcontrib><description>There are provided inter alia compounds of formula (I) wherein R1, R2a, R2b, R3, R4, L, X, R5 and R6 are as defined in the description for use in the treatment of inflammatory diseases.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160512&DB=EPODOC&CC=US&NR=2016130256A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160512&DB=EPODOC&CC=US&NR=2016130256A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HARDY GEORGE</creatorcontrib><creatorcontrib>MURRAY PETER JOHN</creatorcontrib><creatorcontrib>ONIONS STUART THOMAS</creatorcontrib><creatorcontrib>WILLIAMS JONATHAN GARETH</creatorcontrib><creatorcontrib>KING-UNDERWOOD JOHN</creatorcontrib><title>NOVEL COMPOUNDS</title><description>There are provided inter alia compounds of formula (I) wherein R1, R2a, R2b, R3, R4, L, X, R5 and R6 are as defined in the description for use in the treatment of inflammatory diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOD38w9z9VFw9vcN8A_1cwnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoZmhsYGRqZmjobGxKkCAGToHjo</recordid><startdate>20160512</startdate><enddate>20160512</enddate><creator>HARDY GEORGE</creator><creator>MURRAY PETER JOHN</creator><creator>ONIONS STUART THOMAS</creator><creator>WILLIAMS JONATHAN GARETH</creator><creator>KING-UNDERWOOD JOHN</creator><scope>EVB</scope></search><sort><creationdate>20160512</creationdate><title>NOVEL COMPOUNDS</title><author>HARDY GEORGE ; MURRAY PETER JOHN ; ONIONS STUART THOMAS ; WILLIAMS JONATHAN GARETH ; KING-UNDERWOOD JOHN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2016130256A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>HARDY GEORGE</creatorcontrib><creatorcontrib>MURRAY PETER JOHN</creatorcontrib><creatorcontrib>ONIONS STUART THOMAS</creatorcontrib><creatorcontrib>WILLIAMS JONATHAN GARETH</creatorcontrib><creatorcontrib>KING-UNDERWOOD JOHN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HARDY GEORGE</au><au>MURRAY PETER JOHN</au><au>ONIONS STUART THOMAS</au><au>WILLIAMS JONATHAN GARETH</au><au>KING-UNDERWOOD JOHN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL COMPOUNDS</title><date>2016-05-12</date><risdate>2016</risdate><abstract>There are provided inter alia compounds of formula (I) wherein R1, R2a, R2b, R3, R4, L, X, R5 and R6 are as defined in the description for use in the treatment of inflammatory diseases.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_US2016130256A1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
title	NOVEL COMPOUNDS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T12%3A25%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HARDY%20GEORGE&rft.date=2016-05-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2016130256A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true